Latest Esg News

PT Aneka Tambang Tbk (ANTAM) reported a remarkable 197% surge in net profit for the first nine months of 2025, driven by robust gold, nickel, and bauxite sales alongside strategic downstreaming and operational efficiencies.

Brazilian Critical Minerals has reported exceptional results from its in-situ recovery trials at the Ema rare earth project, achieving rare earth concentrations far exceeding in-situ grades and securing strong local government backing.

Richmond Vanadium Technology reports solid progress in its Queensland vanadium project, advancing environmental approvals and feasibility studies while strengthening key industry collaborations.

MONEYME reported a robust start to FY26 with a 26% increase in its loan book and improved credit metrics, driven by strong originations and strategic product expansions.

Australian Strategic Materials (ASM) reports significant progress in rare earth metals production and strategic growth, including a major capital raise and advances in its Dubbo and US projects.

Franklin Templeton Australia has launched the Franklin Australian Absolute Return Bond Fund – Class A, an actively managed fixed income fund now available on the ASX. The fund aims to deliver returns exceeding the Bloomberg AusBond Bank Bill Index with a medium risk profile and transparent fee structure.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

Rubicon Water has landed four key contracts worth A$8.3 million across the US, Italy, and Australia, marking a strong start to its FY26 sales pipeline and introducing a novel private ESG funding source in the US.

Acumentis delivered a 3.4% revenue increase to $58.1 million at its 2025 AGM, highlighting diversification and a positive outlook for FY26 amid easing inflation and expected rate cuts.

GR Engineering Services Limited reported a robust FY25 with revenue climbing to $479 million and EBITDA surging to $57.2 million, supported by successful project completions and an expanded contract pipeline. The company declared a higher fully franked dividend and maintains a strong cash position as it looks ahead to FY26.

Sigma Healthcare’s 2025 AGM reveals a robust year of transformation post-merger with Chemist Warehouse, highlighted by upgraded synergy targets and impressive financial gains.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.